ERA-CRISPR/Cas12a-based, fast and specific diagnostic detection for Chlamydia pneumoniae
Frontiers in Cellular and Infection Microbiology · 01.11.2024 · 14
DOI: 10.3389/fcimb.2024.1477422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 01.11.2024. Verfasst von Yanxia Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Institute of Pathogenic Biology, Hengyang Medical School, University of South China, Hengyang, China. Hauptthemen laut MEDLINE: Chlamydophila pneumoniae, CRISPR-Cas Systems, Sensitivity and Specificity. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chlamydia pneumoniae (C. pneumoniae) is a specialized intracellular parasitic pathogen capable of causing pneumonia, sinusitis, bronchitis, and other respiratory diseases, which pose significant public health challenges. Therefore, rapid, accurate, and sensitive diagnosis is crucial for the prevention and treatment of respiratory diseases caused by C. pneumoniae . In this study, we combined enzymatic recombination amplification (ERA) with the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) 12a system (CRISPR/Cas12a) to develop a dual detection platform termed the Cpn-ERA-CRISPR/Cas12a dual system. This system integrates both the ERA-CRISPR/Cas12a fluorescence system and the ERA-CRISPR/Cas12a lateral flow system. Detection results can be measured using a fluorescence detector or observed with the naked eye on lateral flow strips. The fluorescence system and the lateral flow system detect C. pneumoniae in 30 minutes and 15 minutes, respectively. This dual system exhibits no cross-reactivity with the other seven pathogens, demonstrating high specificity, and achieves a sensitivity of 10 0 copies/µL. Additionally, the Cpn-ERA-CRISPR/Cas12a dual system was employed to analyze 39 clinical samples, comprising 19 positive and 20 negative samples. The detection rate for positive samples was 100%, with no positive results in the negative samples, indicating a high level of concordance with qPCR results. In summary, the Cpn-ERA-CRISPR/Cas12a dual system represents a novel tool for diagnosing C. pneumoniae and holds promising application potential in grassroots community hospitals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Institute of Pathogenic Biology, Hengyang Medical School, University of South China, Hengyang, China.
- Department of Clinical Laboratory, The Second People's Hospital of Foshan, Foshan, China.
- Department of Infection Control, The First People's Hospital of Chenzhou, Chenzhou, China.
- Department of Public Health Laboratory Sciences, College of Public Health, Hengyang Medical School, University of South China, Hengyang, China.
Zitieren
APA
Zhou, Y., Yan, Z., Zhou, S., Li, W., Yang, H., Chen, H., Deng, Z., Zeng, Q., Sun, P., & Wu, Y. (2024). ERA-CRISPR/Cas12a-based, fast and specific diagnostic detection for Chlamydia pneumoniae. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1477422
Vancouver
Zhou Y, Yan Z, Zhou S, Li W, Yang H, Chen H, et al. ERA-CRISPR/Cas12a-based, fast and specific diagnostic detection for Chlamydia pneumoniae. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1477422
BibTeX
@article{Zhou2024,
author = {Zhou, Yanxia and Yan, Zijun and Zhou, Shi and Li, Weiwei and Yang, Hongyu and Chen, Hongliang and Deng, Zhongliang and Zeng, Qilin and Sun, Peiyuan and Wu, Yimou},
title = {ERA-CRISPR/Cas12a-based, fast and specific diagnostic detection for Chlamydia pneumoniae},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
volume = {14},
doi = {10.3389/fcimb.2024.1477422}
}
EUVIMED